Sodium channel protein type 4 subunit alpha
Also known as: SCN4A
Function
Pore-forming subunit of Nav1.4, a voltage-gated sodium (Nav) channel that directly mediates the depolarizing phase of action potentials in excitable membranes. Navs, also called VGSCs (voltage-gated sodium channels) or VDSCs (voltage-dependent sodium channels), operate by switching between closed and open conformations depending on the voltage difference across the membrane. In the open conformation they allow Na(+) ions to selectively pass through the pore, along their electrochemical gradient. The influx of Na+ ions provokes membrane depolarization, initiating the propagation of electrical signals throughout cells and tissues. Highly expressed in skeletal muscles, Nav1.4 generates the action potential crucial for muscle contraction.
Classification
- Family (Pfam)
- PF00520 Ion_trans, PF24609 IQ_SCN5A_C, PF06512 Na_trans_assoc
- InterPro
- Ion_trans_dom, IQ_SCN5A_C, Na_channel_a4su_mammal, Na_channel_asu, Na_chnl_inactivation_gate, Na_trans_assoc_dom, VGCC_Ca_Na, Volt_channel_dom_sf
- Functional cluster
- Membrane Transporters & GPCRs
Experimental structures · PDB · 3
A predicted model is available from AlphaFold.
Gene Ontology · 8
- GO:0005886 plasma membrane
- GO:0001518 voltage-gated sodium channel complex
- GO:0005248 voltage-gated sodium channel activity
- GO:0086002 cardiac muscle cell action potential involved in contraction
- GO:0006936 muscle contraction
- GO:0100001 regulation of skeletal muscle contraction by action potential
- GO:0035725 sodium ion transmembrane transport
- GO:0006814 sodium ion transport
Disease associations
- paramyotonia congenita of Von Eulenburg MONDO:0008195
- hyperkalemic periodic paralysis MONDO:0008224
- potassium-aggravated myotonia MONDO:0018959
- hypokalemic periodic paralysis, type 2 MONDO:0013234
- congenital myasthenic syndrome 16 MONDO:0013620
- congenital myopathy 22A, classic MONDO:0957247
- congenital myopathy 22B, severe fetal MONDO:0957265
Drugs targeting this protein · 59
- OXCARBAZEPINE blocker
- CARBAMAZEPINE blocker
- ETHOTOIN blocker
- BUPIVACAINE blocker
- PRILOCAINE blocker
- MORICIZINE HYDROCHLORIDE blocker
- INDECAINIDE HYDROCHLORIDE blocker
- ORPHENADRINE CITRATE blocker
- BUPIVACAINE HYDROCHLORIDE blocker
- LIDOCAINE HYDROCHLORIDE blocker
- QUINIDINE GLUCONATE blocker
- MEPIVACAINE HYDROCHLORIDE blocker
- PROPARACAINE HYDROCHLORIDE blocker
- DYCLONINE HYDROCHLORIDE blocker
- PRILOCAINE HYDROCHLORIDE blocker
- ETIDOCAINE HYDROCHLORIDE blocker
- MEXILETINE HYDROCHLORIDE blocker
- BENOXINATE HYDROCHLORIDE blocker
- HEXYLCAINE HYDROCHLORIDE blocker
- LEVOBUPIVACAINE HYDROCHLORIDE blocker
- TOCAINIDE HYDROCHLORIDE blocker
- ARTICAINE HYDROCHLORIDE blocker
- PROCAINE HYDROCHLORIDE blocker
- DISOPYRAMIDE PHOSPHATE blocker
- PHENAZOPYRIDINE HYDROCHLORIDE blocker
- ORPHENADRINE HYDROCHLORIDE blocker
- PROPAFENONE HYDROCHLORIDE blocker
- DRONEDARONE HYDROCHLORIDE blocker
- RUFINAMIDE blocker
- TETRACAINE HYDROCHLORIDE blocker
- RANOLAZINE blocker
- PHENYTOIN blocker
- PHENYTOIN SODIUM blocker
- PROPOXYCAINE HYDROCHLORIDE blocker
- ROPIVACAINE HYDROCHLORIDE blocker
- ENCAINIDE HYDROCHLORIDE blocker
- NERISPIRDINE blocker
- RALFINAMIDE blocker
- TOPIRAMATE blocker
- IRAMPANEL blocker
- ESLICARBAZEPINE blocker
- DICHLOROBENZYL ALCOHOL blocker
- EVENAMIDE blocker
- QUINIDINE SULFATE blocker
- CENOBAMATE inhibitor
- COCAINE HYDROCHLORIDE blocker
- LACOSAMIDE blocker
- PROCAINAMIDE HYDROCHLORIDE blocker
- TETRACAINE blocker
- LAMOTRIGINE blocker
- RILUZOLE blocker
- ZONISAMIDE blocker
- LIDOCAINE blocker
- PRIMIDONE blocker
- MEPHENYTOIN blocker
- ESLICARBAZEPINE ACETATE blocker
- PHENACEMIDE blocker
- FOSPHENYTOIN SODIUM blocker
- CHLOROPROCAINE HYDROCHLORIDE blocker
Neighborhood · nearest proteins
Related proteins · sequence + function similarity
- Sodium channel protein type 4 subunit alpha 0.99
- Sodium channel protein type 4 subunit alpha 0.99
- Sodium channel protein type 4 subunit alpha 0.98
- Sodium channel protein type 4 subunit alpha A 0.93
- Sodium channel protein type 4 subunit alpha A 0.92
- Sodium channel protein type 4 subunit alpha A 0.92
- Sodium channel protein 0.91
- Sodium channel protein type 10 subunit alpha 0.90
- Sodium channel protein type 10 subunit alpha 0.90
- Sodium channel protein type 10 subunit alpha 0.90
- Sodium channel protein type 10 subunit alpha 0.90
- Sodium channel protein type 8 subunit alpha 0.90
Co-cited proteins · studied together in the literature
- Voltage-dependent L-type calcium channel subunit alpha-1S 2 shared papers
- Chloride channel protein 1 1 shared papers
- Sodium channel protein type 4 subunit alpha 1 shared papers
- Sodium channel regulatory subunit beta-1 2 shared papers
- Excelsatoxin A 1 shared papers
- Transmembrane protein 233 1 shared papers
- Transmembrane protein 233 1 shared papers
- Sodium channel protein type 9 subunit alpha 1 shared papers
- Sodium channel protein type 8 subunit alpha 1 shared papers
- Sodium channel protein type 9 subunit alpha 2 shared papers
- Sodium channel protein type 9 subunit alpha 1 shared papers
- Sodium channel protein type 8 subunit alpha 2 shared papers
Literature · 62 cited papers
- Pain-causing stinging nettle toxins target TMEM233 to modulate NaV1.7 function. Nat. Commun. · 2023
- Case report: Novel SCN4A variant associated with a severe congenital myasthenic syndrome/myopathy phenotype. Front. Pediatr. · 2022
- Structure of the human voltage-gated sodium channel Nav1.4 in complex with beta1. Science · 2018
- A mutation of SCN1B associated with GEFS+ causes functional and maturation defects of the voltage-dependent sodium channel. Hum. Mutat. · 2018
- Congenital myopathy with 'corona' fibres, selective muscle atrophy, and craniosynostosis associated with novel recessive mutations in SCN4A. Neuromuscul. Disord. · 2017
- A case of non-dystrophic myotonia with concomitant mutations in the SCN4A and CLCN1 genes. J. Neurol. Sci. · 2016
- Analysis of protein-coding genetic variation in 60,706 humans. Nature · 2016
- Loss-of-function mutations in SCN4A cause severe foetal hypokinesia or 'classical' congenital myopathy. Brain · 2016
- A recessive Nav1.4 mutation underlies congenital myasthenic syndrome with periodic paralysis. Neurology · 2016
- SCN4A pore mutation pathogenetically contributes to autosomal dominant essential tremor and may increase susceptibility to epilepsy. Hum. Mol. Genet. · 2015
- Defective fast inactivation recovery of Nav 1.4 in congenital myasthenic syndrome. Ann. Neurol. · 2015
- SCN4A mutation as modifying factor of myotonic dystrophy type 2 phenotype. Neuromuscul. Disord. · 2015
- … and 50 more in the literature graph